Español 药物安全通讯 Drug Safety Podcast 01-11-2024 FDA Drug Safety Communication Drug Safety Communication (PDF – 214 KB) The U.S. Food and Drug Administration (FDA) has been evaluating reports […]
TOPLINE: Initiating medication for opioid use disorder (OUD) within 7 days of a hospital visit reduces the risk for fatal or nonfatal opioid overdose at 6 […]
TOPLINE: Emergency department (ED) visits for falls are linked to a higher short-term risk for ischemic stroke, particularly within 15 days; patients with a preceding fall […]
Image By: Christine Lee, Acting Associate Commissioner for Minority Health, Office of Minority Health and Health Equity In late June, representatives of the U.S. Food and […]
FDA has reevaluated the rationale document titled, “Daptomycin Breakpoints for Enterococci,” submitted by the Clinical and Laboratory Standards Institute (CLSI) to FDA public docket # FDA-2017-N-5925-020 […]
Docket Number: FDA-2022-D-1527 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research Center for Biologics Evaluation and Research The Food and Drug Administration (FDA […]
Docket Number: FDA-2022-D-1527 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research, Office of Regulatory Policy Center for Biologics Evaluation and Research The Food […]
The US Food and Drug Administration (FDA) has expanded the approval of dostarlimab-gxly (Jemperli, GSK) in conjunction with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.